Cargando…
Profile of once-daily zonisamide as monotherapy for treatment of partial seizures in adults
Epilepsy is one of the most common neurologic disorders, affecting about 50 million people around the world. It is recognized that around 50% of patients with newly diagnosed epilepsy become seizure-free with the first drug treatment, so the choice of first antiepileptic drug is crucial. This paper...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3660130/ https://www.ncbi.nlm.nih.gov/pubmed/23700365 http://dx.doi.org/10.2147/DDDT.S43612 |